{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:30:57Z","timestamp":1759617057313},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T00:00:00Z","timestamp":1347321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s11064-012-0877-z","type":"journal-article","created":{"date-parts":[[2012,9,10]],"date-time":"2012-09-10T09:11:34Z","timestamp":1347268294000},"page":"2836-2841","source":"Crossref","is-referenced-by-count":3,"title":["Morphine Exposure During HIV Encephalitis in SCID Mice"],"prefix":"10.1007","volume":"37","author":[{"given":"William R.","family":"Tyor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Young","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cari","family":"Fritz-French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,11]]},"reference":[{"key":"877_CR1","unstructured":"Grigoryan AM., Shouse, RL, Durant, T, Mastro TD, Espinoza L, Chen M, Kajese T, Wei X, Hall HI (2004\u20132007) Div of HIV\/AIDS prevention, national center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC., HIV infection among injection drug users\u201434 states. JAMA 303:126\u2013128"},{"key":"877_CR2","first-page":"94","volume":"16","author":"DB Clifford","year":"2008","unstructured":"Clifford DB (2008) HIV-associated neurocognitive disease continues in the antiretroviral era. Top HIV Med 16:94\u201398","journal-title":"Top HIV Med"},{"key":"877_CR3","unstructured":"Fitting S, Dever SM, Podhaizer EM, Knapp PE, Hauser KF (2012) Opiate drug use and the pathophysiology of neuroaids. Curr HIV Res, [E.pub ahead of print]"},{"key":"877_CR4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1749-6632.2009.05277.x","volume":"1187","author":"A Nath","year":"2010","unstructured":"Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction. Ann NY Acad Sci 1187:122\u2013128","journal-title":"Ann NY Acad Sci"},{"key":"877_CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/QAI.0b013e318229ba41","volume":"58","author":"DA Byrd","year":"2011","unstructured":"Byrd DA, Fellows RP, Morgello S et al (2011) Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr 58:154\u2013162","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Pt 11","key":"877_CR6","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/brain\/121.11.2043","volume":"121","author":"JE Bell","year":"1998","unstructured":"Bell JE, Brettle RP, Chiswick A, Simmonds P (1998) HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121(Pt 11):2043\u20132052","journal-title":"Brain"},{"key":"877_CR7","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1212\/WNL.42.10.1924","volume":"42","author":"OA Selnes","year":"1992","unstructured":"Selnes OA, McArthur JC, Royal W 3rd et al (1992) HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 42:1924\u20131930","journal-title":"Neurology"},{"key":"877_CR8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000109674","volume":"16","author":"M Concha","year":"1997","unstructured":"Concha M, Selnes OA, Vlahov D et al (1997) Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men. Neuroepidemiology 16:78\u201385","journal-title":"Neuroepidemiology"},{"key":"877_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11481-005-9000-4","volume":"1","author":"KF Hauser","year":"2006","unstructured":"Hauser KF, El-Hage N, Buch S et al (2006) Impact of opiate-HIV-1 interactions on neurotoxic signaling. J Neuroimmune Pharmacol 1:98\u2013105","journal-title":"J Neuroimmune Pharmacol"},{"key":"877_CR10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/glia.20148","volume":"50","author":"N El-Hage","year":"2005","unstructured":"El-Hage N, Gurwell JA, Singh IN, Knapp PE, Nath A, Hauser KF (2005) Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 50:91\u2013106","journal-title":"Glia"},{"key":"877_CR11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/glia.20262","volume":"53","author":"N El-Hage","year":"2006","unstructured":"El-Hage N, Wu G, Wang J et al (2006) HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 53:132\u2013146","journal-title":"Glia"},{"key":"877_CR12","doi-asserted-by":"crossref","first-page":"e4093","DOI":"10.1371\/journal.pone.0004093","volume":"3","author":"N El-Hage","year":"2008","unstructured":"El-Hage N, Bruce-Keller AJ, Yakovleva T et al (2008) Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription. PLoS ONE 3:e4093","journal-title":"PLoS ONE"},{"key":"877_CR13","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1021\/pr900926n","volume":"9","author":"S Fitting","year":"2010","unstructured":"Fitting S, Zou S, Chen W, Vo P, Hauser KF, Knapp PE (2010) Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis. J Proteome Res 9:1795\u20131804","journal-title":"J Proteome Res"},{"key":"877_CR14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/13550280902913628","volume":"15","author":"SM Bokhari","year":"2009","unstructured":"Bokhari SM, Yao H, Bethel-Brown C et al (2009) Morphine enhances Tat-induced activation in murine microglia. J Neurovirol 15:219\u2013228","journal-title":"J Neurovirol"},{"key":"877_CR15","doi-asserted-by":"crossref","unstructured":"Podhaizer EM, Zou S, Fitting S et al. (2011) Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain. J Neuroimmune Pharmacol [E.pub ahead of print]","DOI":"10.1007\/s11481-011-9326-z"},{"key":"877_CR16","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1093\/brain\/awr281","volume":"134","author":"S Zou","year":"2011","unstructured":"Zou S, Fitting S, Hahn YK et al (2011) Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at mu-opioid receptor-expressing glia. Brain 134:3616\u20133631","journal-title":"Brain"},{"key":"877_CR17","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/glia.20708","volume":"56","author":"AJ Bruce-Keller","year":"2008","unstructured":"Bruce-Keller AJ, Turchan-Cholewo J, Smart EJ et al (2008) Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice. Glia 56:1414\u20131427","journal-title":"Glia"},{"key":"877_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2012.05.029","volume":"689","author":"S Fitting","year":"2012","unstructured":"Fitting S, Scoggins KL, Xu R et al (2012) Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice. Eur J Pharmacol 689:96\u2013103","journal-title":"Eur J Pharmacol"},{"key":"877_CR19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2353\/ajpath.2010.090945","volume":"177","author":"S Fitting","year":"2010","unstructured":"Fitting S, Xu R, Bull C et al (2010) Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol 177:1397\u20131410","journal-title":"Am J Pathol"},{"key":"877_CR20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11481-011-9324-1","volume":"7","author":"SL Chang","year":"2012","unstructured":"Chang SL, Connaghan KP (2012) Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins. J Neuroimmune Pharmacol 7:332\u2013340","journal-title":"J Neuroimmune Pharmacol"},{"key":"877_CR21","doi-asserted-by":"crossref","first-page":"10010","DOI":"10.1523\/JNEUROSCI.2955-08.2008","volume":"28","author":"VR Rao","year":"2008","unstructured":"Rao VR, Sas AR, Eugenin EA et al (2008) HIV-1 clade-specific differences in the induction of neuropathogenesis. J Neurosci 28:10010\u201310016","journal-title":"J Neurosci"},{"key":"877_CR22","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1523\/JNEUROSCI.5595-08.2009","volume":"29","author":"AR Sas","year":"2009","unstructured":"Sas AR, Bimonte-Nelson H, Smothers CT, Woodward J, Tyor WR (2009) Interferon-alpha causes neuronal dysfunction in encephalitis. J Neurosci 29:3948\u20133955","journal-title":"J Neurosci"},{"key":"877_CR23","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.1073\/pnas.90.18.8658","volume":"90","author":"WR Tyor","year":"1993","unstructured":"Tyor WR, Power C, Gendelman HE, Markham RB (1993) A model of human immunodeficiency virus encephalitis in scid mice. Proc Natl Acad Sci USA 90:8658\u20138662","journal-title":"Proc Natl Acad Sci USA"},{"key":"877_CR24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ana.20479","volume":"57","author":"JE Cook","year":"2005","unstructured":"Cook JE, Dasgupta S, Middaugh LD et al (2005) Highly active antiretroviral therapy and human immunodeficiency virus encephalitis. Ann Neurol 57:795\u2013803","journal-title":"Ann Neurol"},{"key":"877_CR25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2007.03.007","volume":"205","author":"J Cook-Easterwood","year":"2007","unstructured":"Cook-Easterwood J, Middaugh LD, Griffin WC 3rd, Khan I, Tyor WR (2007) Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis. Exp Neurol 205:506\u2013512","journal-title":"Exp Neurol"},{"key":"877_CR26","unstructured":"Tyor WSA, Jones R, Xu R, Knapp P, Hauser K (2009) Opiate Interactions in SCID mice with HIV encephalitis In: American Academy of Neurology 61st Annual Meeting. Seattle, WA"},{"key":"877_CR27","first-page":"1","volume":"2","author":"NG Avgeropoulos","year":"1998","unstructured":"Avgeropoulos NG, Burris GW, Ohlandt GW, Wesselingh SL, Markham RB, Tyor WR (1998) Potential relationships between the presence of HIV, macrophages, and astrogliosis in SCID mice with HIV encephalitis. J NeuroAIDS 2:1\u201320","journal-title":"J NeuroAIDS"},{"key":"877_CR28","first-page":"472","volume-title":"Handbook of neurochemistry and molecular neurobiology","author":"WR Tyor","year":"2009","unstructured":"Tyor WR (2009) Pathogenesis and treatment of HIV-associated dementia: recent studies in a SCID mouse model. In: Banik N (ed) Handbook of neurochemistry and molecular neurobiology. Spinger, Berlin Heidelberg, pp 472\u2013489"},{"key":"877_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03033820","volume":"8","author":"KF Hauser","year":"2005","unstructured":"Hauser KF, El-Hage N, Buch S et al (2005) Molecular targets of opiate drug abuse in neuroAIDS. Neurotox Res 8:63\u201380","journal-title":"Neurotox Res"},{"key":"877_CR30","first-page":"379","volume":"9","author":"WR Tyor","year":"1995","unstructured":"Tyor WR, Wesselingh SL, Griffin JW, McArthur JC, Griffin DE (1995) Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol 9:379\u2013388","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"877_CR31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11481-009-9174-2","volume":"4","author":"A Yadav","year":"2009","unstructured":"Yadav A, Collman RG (2009) CNS inflammation and macrophage\/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol 4:430\u2013447","journal-title":"J Neuroimmune Pharmacol"},{"key":"877_CR32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s13365-011-0047-0","volume":"17","author":"SV Westmoreland","year":"2011","unstructured":"Westmoreland SV, Annamalai L, Lentz MR et al (2011) Growth-associated protein-43 and ephrin B3 induction in the brain of adult SIV-infected rhesus macaques. J Neurovirol 17:455\u2013468","journal-title":"J Neurovirol"},{"key":"877_CR33","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.4049\/jimmunol.1003757","volume":"186","author":"L Alammar","year":"2011","unstructured":"Alammar L, Gama L, Clements JE (2011) Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection. J Immunol 186:4008\u20134018","journal-title":"J Immunol"},{"key":"877_CR34","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s11481-011-9272-9","volume":"6","author":"SM Bokhari","year":"2011","unstructured":"Bokhari SM, Hegde R, Callen S et al (2011) Morphine potentiates neuropathogenesis of SIV infection in rhesus macaques. J Neuroimmune Pharmacol 6:626\u2013639","journal-title":"J Neuroimmune Pharmacol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-012-0877-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-012-0877-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-012-0877-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T16:33:58Z","timestamp":1562171638000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-012-0877-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,11]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1007\/s11064-012-0877-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,11]]}}}